SARS-CoV-2 Antigen Test
Quantitative measurement of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swab
Simultaneous detection of SARS-CoV-2 nucleocapsid protein
Randox have developed an Antigen test for SARS-CoV-2 for the quantitative measurement of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swab samples. Designed to aid in the identification of individuals with SARS-CoV-2, the Randox antigen test provides a timely and accurate diagnosis imperative to limit virus spread and to provide appropriate treatment to patients.
Viral antigens are only expressed when the virus is actively replicating, thus making antigen tests such as the Evidence Investigator SARS-CoV-2 antigen test clinically valuable for identification of acute/early infection.
|54 Biochip Investigator Kit for SARS-CoV-2 Antigen||EV4451/A|
|Control Kit for SARS-CoV-2 Antigen Test||EV4451/B|
Estimated turnaround time: 2.5 hours
Medium throughput (54 samples)
Suitable for laboratory setting
Comprehensive immunoassay and molecular test menu available
Want to know more?
Contact us or visit our COVID-19 Monitoring & Management page